Synthetic chemicals called per- and polyfluoroalkyl substances (PFAS) have been accumulating in the environment since their ...

Amylyx will be allowed to run a Phase I trial after the FDA lifted a clinical hold of its investigational ALS drug.

Valneva has announced positive outcomes from its Phase III trial of the single-shot IXCHIQ chikungunya virus vaccine in ...

To observe the effects of coffee consumption on HNC risk, a study published in Cancer utilised pooled data from the INHANCE ...

The study found that the number of advanced therapy Phase I trials in the UK nearly doubled since the same time in 2023.

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.

SK bioscience and Sanofi have announced global Phase III studies, which will assess the safety and immunogenicity of GBP410.

Results from the single-arm trial saw 63.5% of patients able to avoid the symptoms of Atrial fibrillation over the course of ...

The Clinical Trials Arena spoke to industry experts about what challenges the sector can expect to face in 2025.

The FDA has granted approval for Zydus to proceed with the Phase II(b) trial of Usnoflast for amyotrophic lateral sclerosis (ALS) treatment.

The new pan-European group of 73 regulators, companies and trial sites is backed by €66.8m in funding with a six-year goal.

Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic macular oedema (DMO) treatment.